
Insights Into Ph+ALL & CML
Perspectives on drivers in treatment decisions in the management of philadelphia chromosome-positive (Ph+) acute lymphoblastic Leukemia (ALL) and chronic myeloid leukemia (CML)
Faculty Chair
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
More Information
- Virtual series
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on the treatment philadelphia chromosome-positive (Ph+) acute lymphoblastic Leukemia (ALL) and chronic myeloid leukemia (CML)
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained
- Management Options in Ph+ ALL
- Management Options in CML
- Unmet needs and emerging paradigms
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 10–15 medical oncologists representative of each region